INCLINE VILLAGE, Nev., Oct. 24, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that Harold E. Selick, Ph.D., Chairman of the Board of Directors of PDL BioPharma, has sent the following letter to Engine Capital, LP. October 24, 2019 Arnaud...
from PR Newswire: https://ift.tt/31QEulq
No comments:
Post a Comment